top of page

Exploring Regenerative Medicine: 5 Key Reasons Why DB2 Regeneration Chooses Regenerative Medicine Therapy

Updated: Feb 26

Exploring Regenerative Medicine: 5 Key Reasons Why DB2 Regeneration Chooses Regenerative Medicine Therapy

Regenerative Medicine is a revolutionary field that has gained immense popularity over the last decade, yet many remain unfamiliar with its benefits. In essence, Regenerative Medicine employs human cellular tissue products (HCT/P), natural growth factors, or cellular signaling components to facilitate healing and reduce inflammation. This cutting-edge therapy utilizes either the patient's own harvested products, such as Platelet Rich Plasma (PRP), or voluntarily donated umbilical tissue like Wharton's jelly to restore damaged tissues caused by age, chronic disease, trauma, or osteoarthritis. The approach offers alternatives to traditional methods like steroid injections or surgical joint replacements, allowing for a combination of both regenerative medicine and surgical treatments when necessary.

Why DB2 Regeneration Embraces Regenerative Medicine

1. Conservative Approach

Regenerative Medicine stands out as an exceptionally conservative approach compared to drugs or surgery. Whether using a patient's own tissue or donated tissue, the procedures for procurement and delivery are straightforward, minimally invasive, and often involve simple injections for treatment administration.

2. Convenient Procedures

Due to the minimally invasive nature of regenerative medicine, most procedures can be performed in the office, typically taking less than an hour. Unlike surgeries that demand weeks or months of rehabilitation, regenerative medicine procedures do not require extended recovery periods, allowing patients to return to their normal lives promptly.

3. Cost-Effectiveness

While regenerative medicine treatments are not currently covered by insurance in the United States, the overall cost is often a fraction of surgical or long-term pain medication expenses. This includes considerations like deductibles, co-pays, prescription costs, and time off work.

4. Continuous Impact

Regenerative medicine treatments continue to work long after administration, with effects lasting from over a month to up to a year. The ongoing reduction of inflammation and support for natural healing contribute to the prolonged impact of these treatments.

5. Collaborative Approach

Regenerative Medicine enhances collaboration with other modalities such as physical therapy, chiropractic care, pain management, and orthopedic surgery. It complements these treatments by providing the unique ability to restore damaged tissue, making the overall approach more effective.

DB2 Regeneration Clinics, led by experienced professionals with over 8 years in the field, prioritize regenerative medicine for these key reasons. The clinic emphasizes that regenerative medicine is just one piece of the puzzle for overall health and wellbeing. It enhances various treatments without contradicting their effectiveness, making it a valuable addition to comprehensive healthcare.

Beyond the listed applications, regenerative medicine has broader implications, including breakthroughs in wound care, anti-aging, immune function, and cosmetic applications. At DB2, the adoption of regenerative medicine reflects its low risk and substantial rewards.

To explore how regenerative medicine options at DB2 can benefit you,

appointments can be scheduled

at 636-265-2822


*Referrals are not required.

Reference List

Bradley JP, Lawyer TJ, Ruef S, Towers JD, Arner JW. Platelet-Rich Plasma Shortens Return to Play in National Football League Players With Acute Hamstring Injuries. Orthop J Sports Med. 2020 Apr 17;8(4):2325967120911731. doi: 10.1177/2325967120911731. PMID: 32341927; PMCID:


Setayesh K, Villarreal A, Gottschalk A, Tokish JM, Choate WS. Treatment of Muscle Injuries with Platelet-Rich Plasma: a Review of the Literature. Curr Rev Musculoskelet Med. 2018 Dec;11(4):635-642. doi: 10.1007/s12178-018-9526-8. PMID: 30343400; PMCID: PMC6220013. A Hamid MS, Mohamed Ali MR, Yusof A, George J, Lee LP. Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial. Am J Sports Med. 2014 Oct;42(10):2410-8. doi: 10.1177/0363546514541540. Epub 2014 Jul 29. Erratum in: Am J Sports Med. 2015 May;43(5):NP13. PMID: 25073598. Rahimzadeh P, Imani F, Faiz SHR, Entezary SR, Zamanabadi MN, Alebouyeh MR. The effects of injecting intra-articular platelet-rich plasma or prolotherapy on pain score and function in knee osteoarthritis. Clin Interv Aging. 2018;13:73-79

Cheng J, Santiago KA, Nguyen JT, Solomon JL, Lutz GE. Treatment of symptomatic degenerative intervertebral discs with autologous platelet-rich plasma: follow-up at 5-9 years.

Regen Med. 2019 Sep;14(9):831-840. doi: 10.2217/rme-2019-0040. Epub 2019 Aug 29. PMID: 31464577; PMCID: PMC6770415.

Ashley Smith, Ben Andruski, George Deng, Robert Burnham, Cervical facet joint platelet-rich plasma in people with chronic whiplash-associated disorders: A prospective case series of short-term outcomes, Interventional Pain Medicine, Volume 1, Issue 2, 2022, 100078, ISSN 2772-5944,

Fernando Kirchner, MD1 , Isidro Milani, MD1 , Àlex Martínez, MD1 , Nicolas Kirchner-Bossi, PhD2 , Roberto Prado, PhD3-5, Sabino Padilla, PhD3-5, and Eduardo Anitua, PhD: Plasma Rich in Growth Factors (PRGF) in the Treatment of Cervical and Lumbar Back Pain: A Retrospective Observational Clinical Study. Pain Physician 2021; 24:E649-E660 • ISSN 2150-1149

Krut, Z.; Pelled, G.; Gazit, D.; Gazit, Z. Stem Cells and Exosomes: New Therapies for Intervertebral Disc Degeneration. Cells 2021, 10, 2241. 10.3390/cells10092241

91 views0 comments


bottom of page